Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
393673011000036115 | Banlice Mousse foam | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
393674011000036118 | Banlice Mousse (piperonyl butoxide 16.5 mg / 1 g + pyrethrins 1.65 mg / 1 g) foam (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Banlice Mousse foam | has Australian BoSS | pyrethrins | true | Inferred relationship | Some | 879243692 | |
Banlice Mousse foam | has manufactured dose form | foam | true | Inferred relationship | Some | ||
Banlice Mousse foam | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Banlice Mousse foam | Is a | Banlice Mousse | true | Inferred relationship | Some | ||
Banlice Mousse foam | Is a | pyrethrins 0.165% + piperonyl butoxide 1.65% foam | true | Inferred relationship | Some | ||
Banlice Mousse foam | has unit of use | continuous | true | Inferred relationship | Some | 1080315009 | |
Banlice Mousse foam | has intended active ingredient | piperonyl butoxide | true | Inferred relationship | Some | 1080315008 | |
Banlice Mousse foam | has Australian BoSS | piperonyl butoxide | true | Inferred relationship | Some | 1080315008 | |
Banlice Mousse foam | has intended active ingredient | pyrethrins | true | Inferred relationship | Some | 879243692 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Banlice Mousse foam, 200 g | has TPUU | True | Banlice Mousse foam | Inferred relationship | Some | 1 |
Banlice Mousse foam, 200 g, aerosol can | has TPUU | True | Banlice Mousse foam | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set